MedTrace Logo

Lung Ultrasound for Acute Respiratory Infections by Community Health Workers

NCT03594383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2022-03-31

No results posted yet for this study

Summary

The specific objectives focus on using a train-the-trainer model to educate CHWs in Pakistan on performing and interpreting pediatric lung POCUS. In the first phase, the POCUS experts from Toronto will rigorously train the first generation of local lung POCUS users who are Pakistani health care providers to become local lung POCUS trainers. These first generation trainers will subsequently collaborate with the POCUS experts from Toronto to develop a two-day training program for lung POCUS image interpretation and acquisition that is tailored to novice users (CHWs) in low-resource settings. In the second phase, the first generation local lung POCUS trainers will deliver and evaluate the new training program to the second generation of users - a group of CHWs in Karachi. In the third phase, we will establish the reliability of CHWs to perform lung POCUS on pediatric patients with respiratory symptoms, upon completion of the training program developed by local trainers.

Conditions

Interventions

DEVICE

ULTRASOUND

Lung ultrasound done through POCUS to diagnose pneumonia

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER

  • Grand Challenges Canada

    collaborator OTHER

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Fatima Mir, FCPS · Aga Khan University

Eligibility

Min Age
2 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-12
Primary Completion
2019-12-30
Completion
2021-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594383 on ClinicalTrials.gov